France· FR:67032044
PADCEV 20 mg, poudre pour solution à diluer pour perfusion
A medicinal product containing enfortumab védotine, registered in France by ASTELLAS PHARMA EUROPE (PAYS-BAS).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ENFORTUMAB VÉDOTINE
- Manufacturer
- ASTELLAS PHARMA EUROPE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550867271 flacon(s) en verre de 10 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Enfortumab védotine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsPadcev 20 mg, poeder voor oplossing voor infusieAstellas Pharma Europe B.V.
- FinlandPadcevParanova Oy
- United StatesPADCEVSEAGEN INC.
- SpainPADCEV 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONAstellas Pharma Europe B.V.
- CzechiaPADCEVAstellas Pharma Europe B.V., Leiden
- United KingdomPadcev 20mg powder for concentrate for solution for infusion vialsAstellas Pharma Ltd
- BelgiumPadcev 20 mgAstellas Pharma Europe
- IcelandPadcevAstellas Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Padcev
- Liechtenstein · Padcev
- Norway · Padcev
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/beac4d3a-aa10-48e2-b287-aaeb117456cb GET /v1/drugs/beac4d3a-aa10-48e2-b287-aaeb117456cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67032044",
"date_amm": "2022-04-13",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1615",
"substance": "ENFORTUMAB VÉDOTINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about enfortumab védotine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.